Last reviewed · How we verify
NCT04611412
Determination of Risk Factors for the Development of Obesity and Hypertension in Children According to Perinatal Programming of Metabolism
trial testing Risk Factors in Metabolic Syndrome in 55 participants. Status unknown.
30 December 2023
Quick facts
| Lead sponsor | Samarkand State Medical Institute |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 55 |
| Start date | 15 December 2020 |
| Primary completion | 30 December 2023 |
| Estimated completion | 2 January 2024 |
| Sites | 1 location across Uzbekistan |
Drugs / interventions tested
- Risk Factors
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
Samarkand State Medical Institute
Who can join
Adults 12 to 18, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
to determine the risk factors for developing obesity in children with exogenous-constitutional obesity and arterial hypertension, according to the theories of early programming of metabolism
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04611412
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Risk Factors
Trials testing the same drug.
- NCT04585633 — Postoperative Risk Prediction Score After Elective Intracranial Neurosurgery Operation · unknown
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other Samarkand State Medical Institute trials
Trials by the same sponsor.
- NCT05160259 — Radial Visualization of the Foramen Arcuale Atlantis · active not recruiting
- NCT04562259 — Verification of Kimmerle's Anomaly by X-ray Methods of Research · active not recruiting
- NCT04599621 — Unstable Angina Pectoris in Comorbidity With Anxiety-depressive Syndrome · recruiting
- NCT04605835 — Ultrasonic Visualization of Obstructive Uropathies in Children · unknown
- NCT04613180 — Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04611412 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samarkand State Medical Institute
- Last refreshed: 2 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04611412.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing